G.F. Handeland

433 total citations
8 papers, 369 citations indexed

About

G.F. Handeland is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, G.F. Handeland has authored 8 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Internal Medicine, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Surgery. Recurrent topics in G.F. Handeland's work include Venous Thromboembolism Diagnosis and Management (6 papers), Heparin-Induced Thrombocytopenia and Thrombosis (4 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). G.F. Handeland is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (6 papers), Heparin-Induced Thrombocytopenia and Thrombosis (4 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). G.F. Handeland collaborates with scholars based in Norway. G.F. Handeland's co-authors include Ulrich Abildgaard, H.A. Holm, K Arnesen, Ansgar O. Aasen, Paola Gottschalk, Birgit Scheel, O. Sortland, G Stene-Larsen and D W T Nilsen and has published in prestigious journals such as Thrombosis and Haemostasis, Thrombosis Research and European Journal of Clinical Pharmacology.

In The Last Decade

G.F. Handeland

8 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G.F. Handeland Norway	5	257	208	151	135	35	8	369
M Leaker Canada	6	101 0.4×	99 0.5×	55 0.4×	224 1.7×	39 1.1×	8	319
Arjan A. van den Bos Netherlands	9	175 0.7×	363 1.7×	325 2.2×	88 0.7×	38 1.1×	12	509
E Einarsson Sweden	12	480 1.9×	107 0.5×	448 3.0×	45 0.3×	110 3.1×	26	647
Andrei Kindzelski United States	11	271 1.1×	83 0.4×	208 1.4×	46 0.3×	33 0.9×	12	433
J Conard France	8	113 0.4×	84 0.4×	65 0.4×	138 1.0×	53 1.5×	25	254
Frank C. Vandy United States	11	119 0.5×	96 0.5×	122 0.8×	68 0.5×	103 2.9×	15	293
Emilio Pastor Spain	10	72 0.3×	79 0.4×	54 0.4×	151 1.1×	25 0.7×	26	317
Philip L. Cimo United States	8	63 0.2×	34 0.2×	135 0.9×	223 1.7×	61 1.7×	11	345
Fernando Cura Argentina	9	95 0.4×	421 2.0×	302 2.0×	55 0.4×	79 2.3×	50	524
Anthony T. Chapekis United States	8	89 0.3×	353 1.7×	357 2.4×	41 0.3×	99 2.8×	11	477

Countries citing papers authored by G.F. Handeland

Since Specialization

Citations

This map shows the geographic impact of G.F. Handeland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.F. Handeland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.F. Handeland more than expected).

Fields of papers citing papers by G.F. Handeland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.F. Handeland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.F. Handeland. The network helps show where G.F. Handeland may publish in the future.

Co-authorship network of co-authors of G.F. Handeland

This figure shows the co-authorship network connecting the top 25 collaborators of G.F. Handeland. A scholar is included among the top collaborators of G.F. Handeland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.F. Handeland. G.F. Handeland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Handeland, G.F., Ulrich Abildgaard, H.A. Holm, & K Arnesen. (1990). Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin. European Journal of Clinical Pharmacology. 39(2). 107–112. 150 indexed citations

2.

Arnesen, K, G.F. Handeland, Ulrich Abildgaard, et al.. (1987). WHAT IS THE OPTIMAL DOSAGE OF LMW HEPARIN IN THE SC TREATMENT OF DEEP VENOUS THROMBOSIS. Thrombosis and Haemostasis. 2 indexed citations

3.

Holm, H.A., G.F. Handeland, Ulrich Abildgaard, et al.. (1986). Subcutaneous Heparin Treatment of Deep Venous Thrombosis: A Comparison of Unfractionated and Low Molecular Weight Heparin. Pathophysiology of Haemostasis and Thrombosis. 16(Suppl. 2). 30–37. 118 indexed citations

4.

Handeland, G.F., et al.. (1986). Heparin cofactor II activity in plasma: Application of an automated assay method to the study of a normal adult population. Scandinavian Journal of Haematology. 36(1). 96–102. 25 indexed citations

5.

Handeland, G.F.. (1986). Simplified chromogenic substrate assay for low molecular weight heparin. Thrombosis Research. 42(1). 105–108. 4 indexed citations

6.

Handeland, G.F. & Ulrich Abildgaard. (1985). In vivo recovery of antithrombin concentrates. Thrombosis Research. 39(1). 133–138. 4 indexed citations

7.

Handeland, G.F. & Ulrich Abildgaard. (1984). Assay of unfractionated and LMW heparin with chromogenic substrates: Twin methods with factor Xa and thrombin. Thrombosis Research. 35(6). 627–636. 20 indexed citations

8.

Handeland, G.F., Ulrich Abildgaard, & Ansgar O. Aasen. (1983). Simplified Assay for Antithrombin III Activity Using Chromogenic Peptide Substrate. Scandinavian Journal of Haematology. 31(5). 427–436. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact